Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even ...
The rate of warnings initiated by the FDA continues to rise in the pharma and medical device industries. Knowing how to best ...
Applied Therapeutics, a clinical-stage biopharmaceutical company, is under heightened scrutiny following the issuance of a November 2024 ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
As certain weight-loss drugs have become increasingly popular, scammers are taking notice and coming out of the woodwork to ...
KTVZ News has an update Friday on our previous reports about the sometimes tragic results from use of Librela, a once-monthly ...
Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of AI in medical product development, ...
According to the American Kennel Club, side-effects from the drug Librela included a skin ... “I just wish there was more of like a black box warning surrounding it, more of reflecting the ...
After market hours on December 2, 2024, Applied Therapeutics disclosed it received a "warning letter" from the FDA referring to the clinical trial issues underlying the CRL. Applied Therapeutics' ...
Applied Therapeutics has been sent a warning letter from the FDA over a clinical trial of its rare disease therapy govorestat, which was rejected by the agency last week. The letter – addressed ...
The UK-based firm has issued five Class II recalls for its RX-series analyzers since 2018 for issues related to reagent carryover between subsequent tests.